{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:27:06Z","timestamp":1762867626348,"version":"build-2065373602"},"reference-count":16,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.endien.2021.01.001","type":"journal-article","created":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T17:19:42Z","timestamp":1623518382000},"page":"141-143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Recent developments in the management of Cushing's syndrome"],"prefix":"10.1016","volume":"68","author":[{"given":"Pablo","family":"Abell\u00e1n Galiana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.endien.2021.01.001_bib0005","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1055\/s-0033-1349124","article-title":"Automatic face classification of Cushing\u2019s syndrome in women\u2014a novel screening approach","volume":"121","author":"Kosilek","year":"2013","journal-title":"Exp Clin Endocrinol Diabetes."},{"key":"10.1016\/j.endien.2021.01.001_bib0010","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1055\/a-0887-4233","article-title":"Computer vision technology in the differential diagnosis of Cushing\u2019s syndrome","volume":"127","author":"Popp","year":"2019","journal-title":"Exp Clin Endocrinol Diabetes."},{"key":"10.1016\/j.endien.2021.01.001_bib0015","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1159\/000502211","article-title":"Deep-learning approach to automatic identification of facial anomalies in endocrine disorders","volume":"110","author":"Wei","year":"2020","journal-title":"Neuroendocrinology."},{"key":"10.1016\/j.endien.2021.01.001_bib0020","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvaa107","article-title":"Prospective evaluation of late-night salivary cortisol and cortisone by EIA and LC-MS\/MS in suspected Cushing syndrome","volume":"4","author":"Kannankeril","year":"2020","journal-title":"J Endocr Soc."},{"key":"10.1016\/j.endien.2021.01.001_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clinbiochem.2018.09.010","article-title":"Hair cortisol analysis: an update on methodological considerations and clinical applications","volume":"63","author":"Greff","year":"2019","journal-title":"Clin Biochem."},{"key":"10.1016\/j.endien.2021.01.001_bib0030","first-page":"171","article-title":"Hair glucocorticoids as a biomarker for endogenous Cushing\u2019s syndrome: validation in two independent cohorts","volume":"109","author":"Savas","year":"2019","journal-title":"NEN."},{"key":"10.1016\/j.endien.2021.01.001_bib0035","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa564","article-title":"Human corticotropin-releasing hormone tests: 10 years of real-life experience in pituitary and adrenal disease","volume":"105","author":"Ceccato","year":"2020","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.endien.2021.01.001_bib0040","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/EC-19-0435","article-title":"Approach to patients with pseudo-Cushing\u2019s states","volume":"9","author":"Scaroni","year":"2020","journal-title":"Endocr Connect."},{"key":"10.1016\/j.endien.2021.01.001_bib0045","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa409","article-title":"Non-invasive diagnostic strategy in ACTH-dependent Cushing\u2019s syndrome","volume":"105","author":"Frete","year":"2020","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.endien.2021.01.001_bib0050","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s12020-019-01944-7","article-title":"CRH stimulation improves 18F-FDG-PET detection of pituitary adenomas in Cushing\u2019s disease","volume":"65","author":"Boyle","year":"2019","journal-title":"Endocrine."},{"key":"10.1016\/j.endien.2021.01.001_bib0055","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S2213-8587(20)30240-0","article-title":"Efficacy and safety of osilodrostat in patients with Cushing\u2019s disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase","volume":"8","author":"Pivonello","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.endien.2021.01.001_bib0060","article-title":"Metyrapone treatment in endogenous Cushing\u2019s syndrome: results from a prospective multicenter, open-label, phase III\/IV study: prompt","volume":"70","author":"Nieman","year":"2020","journal-title":"Endocrine Abstracts."},{"key":"10.1016\/j.endien.2021.01.001_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/js.2018-00269","article-title":"Continuous etomidate infusion for the management of severe Cushing syndrome: validation of a standard protocol","volume":"3","author":"Carroll","year":"2019","journal-title":"J Endocr Soc."},{"key":"10.1016\/j.endien.2021.01.001_bib0070","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1530\/EJE-20-0380","article-title":"Etomidate infusion at low doses is an effective and safe treatment for severe Cushing\u2019s syndrome outside intensive care","volume":"183","author":"Constantinescu","year":"2020","journal-title":"Eur J Endocrinol."},{"key":"10.1016\/j.endien.2021.01.001_bib0075","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11102-019-01021-2","article-title":"Pasireotide treatment significantly reduces tumor volume in patients with Cushing\u2019s disease: results from a Phase 3 study","volume":"23","author":"Lacroix","year":"2020","journal-title":"Pituitary."},{"key":"10.1016\/j.endien.2021.01.001_bib0080","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1007\/s40618-020-01246-0","article-title":"Long-acting pasireotide improves clinical signs and quality of life in Cushing\u2019s disease: results from a phase III study","volume":"43","author":"Lacroix","year":"2020","journal-title":"J Endocrinol Invest."}],"container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530018021000378?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530018021000378?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:14:51Z","timestamp":1762866891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2530018021000378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S2530018021000378"],"URL":"https:\/\/doi.org\/10.1016\/j.endien.2021.01.001","relation":{},"ISSN":["2530-0180"],"issn-type":[{"type":"print","value":"2530-0180"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent developments in the management of Cushing's syndrome","name":"articletitle","label":"Article Title"},{"value":"Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.endien.2021.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.endinu.2021.01.002","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 SEEN and SED. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}